New instructions to recommend against using samples with visibly high level of blood.
Source facts
Action
Letters were sent to customers January 25-27, 2005 via overnight mail. Letters advised the customers of the issue and included a new package insert. The firm included a revised package insert to clarify precautions. The firm sent a CORRECTED COPY letter dated January 31, 2005 outlining the changes made in the product insert.
Initiated
2005-01-25
Root cause
Other
Terminated
2005-04-21
Distribution
Product was distributed to 93 hospitals and medical centers located throughout the US
Recall number
Z-0659-05
Recall status
Terminated
CDRH record ID
37189
FDA classified
2005-03-29
Recall event number
31123
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.